Compare Equinor ASA (EQNR) vs 10X Genomics Inc (TXG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Equinor ASA vs 10X Genomics Inc — how do they compare? Equinor ASA trades at $40.81 (market cap $97.58B), while 10X Genomics Inc trades at $58.7 (market cap $7.61B). The key difference: Equinor ASA is far larger — about 12.8× 10X Genomics Inc's market cap, and Equinor ASA pays a 3.81% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| EQNR | TXG | |
|---|---|---|
Market Cap | $97.58B | $7.61B |
Sector | Energy | Health |
52-Week High | $42.40 | $58.57 |
52-Week Low | $22.41 | $11.34 |
Enterprise Value | $106.28B | $7.14B |
Dividend Yield | 3.81% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Equinor ASA
Equinor is a Norway-based integrated oil and gas company. It has been publicly listed since 2001, but the government retains a 67% stake. Operating primarily on the Norwegian Continental Shelf, the firm produced 2.1 million barrels of oil equivalent per day in 2021 (52% oil) and ended the year with 5.4 billion barrels of proven reserves (49% oil). Operations also include offshore wind, solar, oil refineries and natural gas processing, marketing, and trading.
Read more on EQNR →About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →
